Balance Sheet Onto Innovation Inc.

Equities

ONTO

US6833441057

Semiconductor Equipment & Testing

Market Closed - Nyse Other stock markets 16:00:02 2026-05-20 EDT			5-day change	1st Jan Change
263.12 ^USD	+6.06%		-5.00%	+66.68%

05-19	Can Nvidia Do It Again?
05-19	Onto Innovation Prices Upsized $1.3 Billion Convertible Notes Due 2031	MT

d2a6a6501a0c6bd23.EJfOvHC-TPNBabiouQTvHGqSUKwNBI_rCONSd49xb0I.YMC3jwj3YbRxKMHn-zalLyTDNp1Ya7m7S4B_ONYVXhJn_vv9BowfuwxR9Q

Published financial data: ONTO INNOVATION INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: January	2021	2022	2023	2024	2025
Revenues	789M	1.01B	816M	987M	1.01B
Total Revenues	789M	1.01B	816M	987M	1.01B
Cost of Goods Sold, Total	359M	466M	396M	472M	457M
Gross Profit	429M	539M	420M	515M	549M
Selling General & Admin Expenses, Total	125M	135M	145M	162M	165M
R&D Expenses	96.12M	112M	104M	117M	132M
Amortization of Goodwill and Intangible Assets - (IS)	51.37M	55.28M	54.82M	49.44M	39.41M
Other Operating Expenses, Total	273M	303M	304M	328M	336M
Operating Income	157M	237M	116M	187M	213M
Interest Expense, Total	-	-	-	-	-
Interest And Investment Income	1.16M	5.01M	20.36M	33.49M	34.97M
Net Interest Expenses	1.16M	5.01M	20.36M	33.49M	34.97M
Currency Exchange Gains (Loss)	-2.02M	-73K	-4.09M	-276K	-4.43M
Other Non Operating Income (Expenses)	132K	-68K	239K	131K	-565K
EBT, Excl. Unusual Items	156M	242M	133M	220M	243M
Restructuring Charges	-	-	-	-	-63.39M
Merger & Related Restructuring Charges	-393K	-	-	-	-16.5M
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Insurance Settlements	-	-	-	-	-
Legal Settlements	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	156M	242M	133M	220M	163M
Income Tax Expense	13.33M	18.25M	11.42M	18.78M	26.14M
Earnings From Continuing Operations	142M	223M	121M	202M	137M
Net Income to Company	142M	223M	121M	202M	137M
Net Income - (IS)	142M	223M	121M	202M	137M
Net Income to Common Incl Extra Items	142M	223M	121M	202M	137M
Net Income to Common Excl. Extra Items	142M	223M	121M	202M	137M
Per Share Items
Net EPS - Basic	2.89	4.52	2.47	4.09	2.78
Basic EPS - Continuing Operations	2.89	4.52	2.47	4.09	2.78
Basic Weighted Average Shares Outstanding	49.24M	49.42M	48.97M	49.34M	49.12M
Net EPS - Diluted	2.86	4.49	2.46	4.06	2.78
Diluted EPS - Continuing Operations	2.86	4.49	2.46	4.06	2.78
Diluted Weighted Average Shares Outstanding	49.73M	49.76M	49.32M	49.66M	49.27M
Normalized Basic EPS	1.98	3.05	1.69	2.79	3.09
Normalized Diluted EPS	1.96	3.03	1.68	2.77	3.08
Supplemental Items
EBITDA	223M	301M	183M	249M	273M
EBITA	208M	292M	171M	237M	252M
EBIT	157M	237M	116M	187M	213M
EBITDAR	229M	308M	190M	256M	280M
Effective Tax Rate - (Ratio)	8.56	7.55	8.62	8.52	16.05
Current Domestic Taxes	22.8M	48.95M	29.2M	41.84M	7.28M
Current Foreign Taxes	3.15M	2.9M	4.65M	3.41M	5.99M
Total Current Taxes	25.95M	51.85M	33.85M	45.25M	13.28M
Deferred Domestic Taxes	-10.02M	-33.13M	-22.19M	-26.16M	13.7M
Deferred Foreign Taxes	-2.6M	-473K	-242K	-318K	-832K
Total Deferred Taxes	-12.62M	-33.6M	-22.43M	-26.48M	12.86M
Normalized Net Income	97.55M	151M	82.86M	138M	152M
Interest on Long-Term Debt	-	-	-	-	-
Supplemental Operating Expense Items
Selling and Marketing Expenses	57.24M	65.69M	61.76M	76.16M	69.96M
General and Administrative Expenses	67.96M	69.58M	83.15M	85.85M	94.58M
Research And Development Expense From Footnotes	96.12M	112M	104M	117M	132M
Net Rental Expense, Total	5.96M	6.37M	6.53M	6.4M	7M
Stock-Based Comp., COGS (Total)	-	-	-	4.77M	4.16M
Stock-Based Comp., R&D Exp. (Total)	-	-	-	5.5M	4.74M
Stock-Based Comp., S&M Exp. (Total)	-	-	-	5.61M	4.19M
Stock-Based Comp., G&A Exp. (Total)	-	-	-	12.7M	14.05M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	19.54M	24.43M	25.51M	-	478K
Total Stock-Based Compensation	19.54M	24.43M	25.51M	28.58M	27.62M

Fiscal Period: January	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	170M	176M	234M	213M	346M
Short Term Investments	342M	372M	464M	639M	294M
Total Cash And Short Term Investments	511M	548M	698M	852M	640M
Accounts Receivable, Total	177M	241M	227M	308M	269M
Other Receivables	-	-	-	-	-
Total Receivables	177M	241M	227M	308M	269M
Inventory	243M	324M	328M	287M	298M
Prepaid Expenses	16.43M	21.41M	31.13M	30.07M	61.13M
Other Current Assets, Total	-	-	-	-	89K
Total Current Assets	948M	1.13B	1.28B	1.48B	1.27B
Gross Property Plant And Equipment	146M	165M	180M	204M	228M
Accumulated Depreciation	-46.53M	-52.19M	-57.91M	-66.27M	-84.33M
Net Property Plant And Equipment	99.58M	113M	122M	138M	143M
Goodwill	316M	316M	316M	330M	644M
Other Intangibles, Total	277M	222M	167M	127M	298M
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	4.82M	4.78M	18.84M	42.81M	3.86M
Other Long-Term Assets, Total	4.23M	4.48M	2.45M	1.51M	10.3M
Total Assets	1.65B	1.79B	1.91B	2.12B	2.37B
Liabilities
Accounts Payable, Total	53.34M	54.53M	49.87M	56.26M	108M
Accrued Expenses, Total	34.86M	38.91M	38.45M	41.36M	45.31M
Current Portion of Leases	3.97M	5.68M	5.49M	5.42M	6.22M
Current Income Taxes Payable	6.32M	1.91M	3.21M	8.49M	5.26M
Unearned Revenue Current, Total	29.98M	30.16M	24.76M	33.83M	31.78M
Other Current Liabilities	26.06M	29.37M	25.94M	24.74M	22.7M
Total Current Liabilities	155M	161M	148M	170M	219M
Long-Term Leases	13.75M	16.34M	14.03M	9.74M	11.26M
Unearned Revenue Non Current	1.69M	2.85M	2.46M	4.01M	6.25M
Deferred Tax Liability Non Current	40.28M	7.37M	-	4K	20.4M
Other Non Current Liabilities	13.5M	11.32M	8.96M	7.36M	10.24M
Total Liabilities	224M	198M	173M	191M	267M
Common Stock, Total	49K	49K	49K	49K	50K
Additional Paid In Capital	1.26B	1.24B	1.26B	1.28B	1.37B
Retained Earnings	169M	363M	482M	665M	744M
Comprehensive Income and Other	1.32M	-10.01M	-7.9M	-13.86M	-10.02M
Total Common Equity	1.43B	1.6B	1.74B	1.93B	2.1B
Total Equity	1.43B	1.6B	1.74B	1.93B	2.1B
Total Liabilities And Equity	1.65B	1.79B	1.91B	2.12B	2.37B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	49.36M	48.75M	49.13M	49.27M	49.7M
ECS Total Common Shares Outstanding	49.3M	48.68M	49.09M	49.24M	49.7M
Book Value / Share	28.93	32.79	35.38	39.11	42.26
Tangible Book Value	833M	1.06B	1.25B	1.47B	1.16B
Tangible Book Value Per Share	16.9	21.74	25.53	29.82	23.31
Total Debt	17.72M	22.02M	19.52M	15.16M	17.48M
Net Debt	-494M	-526M	-678M	-837M	-622M
Debt Equivalent Oper. Leases	47.71M	50.94M	52.22M	51.2M	56M
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	157M	231M	234M	177M	208M
Inventories - Work In Process, Total	60.42M	69.07M	67.82M	91.67M	59.76M
Inventories - Finished Goods, Total	25.35M	24.18M	25.49M	18.49M	30.44M
Land - (BS)	48.3M	50.34M	47.89M	46.58M	47.77M
Machinery, Total	66.62M	75.29M	91.54M	123M	140M
Full Time Employees	1.41K	1.64K	1.5K	1.55K	1.62K
Accumulated Allowance for Doubtful Accounts (Supple)	1.3M	1.57M	2.66M	2.58M	2.46M
Order Backlog	-	-	-	-	-

Fiscal Period: January	2021	2022	2023	2024	2025
Net Income	142M	223M	121M	202M	137M
Depreciation & Amortization - CF	14.44M	9.38M	12.39M	12.87M	21.03M
Amortization of Goodwill and Intangible Assets - (CF)	51.37M	55.28M	54.82M	49.44M	39.41M
Depreciation & Amortization, Total	65.8M	64.66M	67.21M	62.31M	60.44M
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-4.73M
Asset Writedown & Restructuring Costs	-	5.65M	-	4.17M	-
Stock-Based Compensation (CF)	19.54M	24.43M	25.51M	28.58M	27.62M
Provision and Write-off of Bad Debts	-	-	-	-	-
Other Operating Activities, Total	-1.78M	-24.85M	-9.42M	-6.57M	48.18M
Change In Accounts Receivable	-27.83M	-65.14M	12.15M	-83.68M	53.78M
Change In Inventories	-57.18M	-93.9M	-16.46M	19.94M	-3.03M
Change In Accounts Payable	12.14M	1.18M	-4.68M	6.22M	50.94M
Change in Unearned Revenues	-	-	-	-	-
Change In Income Taxes	1.31M	-5.01M	1.8M	3.11M	-20.16M
Change in Other Net Operating Assets	20.93M	6.35M	-25.29M	9.93M	-21.47M
Cash from Operations	175M	137M	172M	246M	328M
Capital Expenditure	-12.04M	-18.4M	-22.57M	-31.9M	-28.51M
Sale of Property, Plant, and Equipment	-	-	2.8M	-	-
Cash Acquisitions	-23.8M	-4.64M	-	-26.76M	-436M
Sale (Purchase) of Intangible assets	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-106M	-32.64M	-83.61M	-168M	343M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-142M	-55.69M	-103M	-227M	-122M
Long-Term Debt Repaid, Total	-	-	-	-	-
Total Debt Repaid	-	-	-	-	-
Issuance of Common Stock	10.07M	8.07M	5.28M	9.18M	13.4M
Repurchase of Common Stock	-7.4M	-74.13M	-13.96M	-44.11M	-88.55M
Other Financing Activities, Total	-	-2.29M	-801K	-737K	-
Cash from Financing	2.67M	-68.35M	-9.48M	-35.67M	-75.15M
Foreign Exchange Rate Adjustments	-3.28M	-6.39M	-1.48M	-4.02M	1.58M
Miscellaneous Cash Flow Adjustments	-	-1K	-	-	-
Net Change in Cash	32.88M	6.27M	57.64M	-20.56M	133M
Supplemental Items
Cash Interest Paid	-	-	-	-	-
Cash Income Tax Paid (Refund)	23.77M	58.69M	34.1M	35.5M	36.04M
Levered Free Cash Flow	127M	72.61M	132M	159M	237M
Unlevered Free Cash Flow	127M	72.61M	132M	159M	237M
Change In Net Working Capital	43.87M	146M	11.02M	17.3M	-44.84M
Net Debt Issued / Repaid	-	-	-	-	-

Fiscal Period: January	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.29	8.59	3.92	5.81	5.93
Return on Total Capital	7.18	9.66	4.3	6.33	6.55
Return On Equity %	10.58	14.78	7.27	11.01	6.79
Return on Common Equity	10.58	14.78	7.27	11.01	6.79
Margin Analysis
Gross Profit Margin %	54.44	53.64	51.51	52.19	54.59
SG&A Margin	15.87	13.46	17.76	16.41	16.37
EBITDA Margin %	28.22	29.98	22.47	25.26	27.18
EBITA Margin %	26.39	29.05	20.95	23.96	25.09
EBIT Margin %	19.88	23.55	14.23	18.95	21.17
Income From Continuing Operations Margin %	18.04	22.22	14.85	20.43	13.6
Net Income Margin %	18.04	22.22	14.85	20.43	13.6
Net Avail. For Common Margin %	18.04	22.22	14.85	20.43	13.6
Normalized Net Income Margin	12.36	15.02	10.16	13.95	15.09
Levered Free Cash Flow Margin	16.15	7.22	16.14	16.07	23.61
Unlevered Free Cash Flow Margin	16.15	7.22	16.14	16.07	23.61
Asset Turnover
Asset Turnover	0.51	0.58	0.44	0.49	0.45
Fixed Assets Turnover	7.61	9.47	6.95	7.6	7.15
Receivables Turnover (Average Receivables)	4.83	4.8	3.49	3.69	3.48
Inventory Turnover (Average Inventory)	1.66	1.64	1.21	1.54	1.56
Short Term Liquidity
Current Ratio	6.14	7.07	8.69	8.69	5.79
Quick Ratio	4.46	4.92	6.26	6.82	4.15
Operating Cash Flow to Current Liabilities	1.13	0.85	1.16	1.44	1.5
Days Sales Outstanding (Average Receivables)	76.76	75.79	104.39	98.56	106.49
Days Outstanding Inventory (Average Inventory)	224.16	221.62	299.97	237.04	237.8
Average Days Payable Outstanding	42.18	35.88	47.61	44.79	65.01
Cash Conversion Cycle (Average Days)	258.74	261.53	356.76	290.81	279.28
Long Term Solvency
Total Debt/Equity	1.24	1.38	1.12	0.79	0.83
Total Debt / Total Capital	1.23	1.36	1.11	0.78	0.82
LT Debt/Equity	0.96	1.02	0.81	0.51	0.54
Long-Term Debt / Total Capital	0.95	1.01	0.8	0.5	0.53
Total Liabilities / Total Assets	13.56	11.06	9.07	9.03	11.28
EBIT / Interest Expense	-	-	-	-	-
EBITDA / Interest Expense	-	-	-	-	-
(EBITDA - Capex) / Interest Expense	-	-	-	-	-
Total Debt / EBITDA	0.08	0.07	0.1	0.06	0.06
Net Debt / EBITDA	-2.16	-1.71	-3.57	-3.27	-2.22
Total Debt / (EBITDA - Capex)	0.08	0.08	0.12	0.07	0.07
Net Debt / (EBITDA - Capex)	-2.28	-1.82	-4.06	-3.74	-2.47
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	41.76	27.42	-18.83	21.01	1.82
Gross Profit, 1 Yr. Growth %	48.54	25.55	-22.06	22.62	3.66
EBITDA, 1 Yr. Growth %	112.14	35.39	-39.18	36.08	0.28
EBITA, 1 Yr. Growth %	128.5	40.27	-41.47	38.41	-2.85
EBIT, 1 Yr. Growth %	319.76	50.97	-50.96	61.19	1.25
Earnings From Cont. Operations, 1 Yr. Growth %	358.82	56.89	-45.75	66.45	-32.19
Net Income, 1 Yr. Growth %	358.82	56.89	-45.75	66.45	-32.19
Normalized Net Income, 1 Yr. Growth %	315.69	54.79	-45.12	66.27	-0.3
Diluted EPS Before Extra, 1 Yr. Growth %	353.97	56.99	-45.21	65.04	-31.53
Accounts Receivable, 1 Yr. Growth %	18.73	36.22	-6.15	36.01	-12.72
Inventory, 1 Yr. Growth %	27.14	33.39	1.08	-12.45	3.93
Net Property, Plant and Equip., 1 Yr. Growth %	-7.47	13.2	8.2	12.98	4.08
Total Assets, 1 Yr. Growth %	12.37	8.79	6.4	10.86	11.84
Tangible Book Value, 1 Yr. Growth %	30.2	27.07	18.42	17.16	-21.1
Common Equity, 1 Yr. Growth %	12.75	11.95	8.78	10.9	9.07
Cash From Operations, 1 Yr. Growth %	65.38	-22.01	25.8	42.86	33.64
Capital Expenditures, 1 Yr. Growth %	214.42	52.88	22.65	41.33	-10.63
Levered Free Cash Flow, 1 Yr. Growth %	23.69	-43.02	81.36	20.46	37.18
Unlevered Free Cash Flow, 1 Yr. Growth %	23.69	-43.02	81.36	20.46	37.18
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	60.59	34.4	1.69	-0.89	11
Gross Profit, 2 Yr. CAGR %	68.99	36.56	-1.08	-2.24	13.32
EBITDA, 2 Yr. CAGR %	144.78	69.47	-9.26	-9.03	18.72
EBITA, 2 Yr. CAGR %	158.36	79.03	-9.39	-10	17.88
EBIT, 2 Yr. CAGR %	174.95	151.73	-13.96	-11.09	29.61
Earnings From Cont. Operations, 2 Yr. CAGR %	763.3	168.3	-7.74	-4.97	6.24
Net Income, 2 Yr. CAGR %	763.3	168.3	-7.74	-4.97	6.24
Normalized Net Income, 2 Yr. CAGR %	148.93	153.66	-7.83	-4.47	30.22
Diluted EPS Before Extra, 2 Yr. CAGR %	590.41	166.96	-7.26	-4.91	6.31
Accounts Receivable, 2 Yr. CAGR %	19.71	27.18	13.07	12.98	8.95
Inventory, 2 Yr. CAGR %	17.48	30.23	16.11	-5.93	-4.61
Net Property, Plant and Equip., 2 Yr. CAGR %	-9.66	2.35	10.67	10.57	8.44
Total Assets, 2 Yr. CAGR %	6.72	10.57	7.59	8.61	11.35
Tangible Book Value, 2 Yr. CAGR %	19.33	28.62	22.67	17.79	-3.86
Common Equity, 2 Yr. CAGR %	6.22	12.35	10.35	9.83	9.99
Cash From Operations, 2 Yr. CAGR %	210.8	13.57	-0.95	34.06	38.17
Capital Expenditures, 2 Yr. CAGR %	33.04	119.24	36.93	31.66	12.39
Levered Free Cash Flow, 2 Yr. CAGR %	28.99	-16.05	1.65	47.81	31.01
Unlevered Free Cash Flow, 2 Yr. CAGR %	28.99	-16.05	1.65	47.81	31.01
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	42.3	48.67	13.6	7.77	0
Gross Profit, 3 Yr. CAGR %	42.55	53.05	13.28	6.26	0.58
EBITDA, 3 Yr. CAGR %	57.05	100.93	20.43	3.86	-3.21
EBITA, 3 Yr. CAGR %	58.16	110.77	23.33	4.35	-4.76
EBIT, 3 Yr. CAGR %	45.33	125.15	45.93	6.07	-3.49
Earnings From Cont. Operations, 3 Yr. CAGR %	46.69	389	57.48	12.31	-15.08
Net Income, 3 Yr. CAGR %	46.69	389	57.48	12.31	-15.08
Normalized Net Income, 3 Yr. CAGR %	43.3	112.47	52.28	12.2	0.17
Diluted EPS Before Extra, 3 Yr. CAGR %	18.02	321.4	57.47	12.39	-14.77
Accounts Receivable, 3 Yr. CAGR %	40.28	24.98	14.93	20.25	3.67
Inventory, 3 Yr. CAGR %	35.92	22.56	19.68	5.69	-2.75
Net Property, Plant and Equip., 3 Yr. CAGR %	74.09	-2.6	4.26	11.44	8.36
Total Assets, 3 Yr. CAGR %	58.03	7.41	9.16	8.67	9.67
Tangible Book Value, 3 Yr. CAGR %	35.89	21.86	25.13	20.8	3.06
Common Equity, 3 Yr. CAGR %	57.95	8.09	11.15	10.53	9.58
Cash From Operations, 3 Yr. CAGR %	70.94	96.03	17.51	11.91	33.92
Capital Expenditures, 3 Yr. CAGR %	16.87	39.35	80.65	38.38	15.71
Levered Free Cash Flow, 3 Yr. CAGR %	147.54	-1.76	8.52	7.57	48.42
Unlevered Free Cash Flow, 3 Yr. CAGR %	147.54	-1.76	8.52	7.57	48.42
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	27.65	31.56	24.41	26.41	12.55
Gross Profit, 5 Yr. CAGR %	28.3	31.99	23.16	27.93	13.67
EBITDA, 5 Yr. CAGR %	38.49	41.99	26.11	46.35	21.1
EBITA, 5 Yr. CAGR %	39.06	43.36	26.57	49.96	22.59
EBIT, 5 Yr. CAGR %	32.98	38.6	17.84	55.26	41.62
Earnings From Cont. Operations, 5 Yr. CAGR %	30.96	46.67	21.86	153.93	34.54
Net Income, 5 Yr. CAGR %	30.96	46.67	21.86	153.93	34.54
Normalized Net Income, 5 Yr. CAGR %	34.68	38.85	20.11	54.32	45.26
Diluted EPS Before Extra, 5 Yr. CAGR %	19.78	28.73	7.17	132.31	34.57
Accounts Receivable, 5 Yr. CAGR %	22.24	29.89	28.69	20.03	12.5
Inventory, 5 Yr. CAGR %	30	36.87	27.62	10.26	9.3
Net Property, Plant and Equip., 5 Yr. CAGR %	53.05	45.41	45.24	2.47	5.91
Total Assets, 5 Yr. CAGR %	37.25	35.99	35.5	7.88	10.03
Tangible Book Value, 5 Yr. CAGR %	26.13	28.51	30.44	20.21	12.61
Common Equity, 5 Yr. CAGR %	37.16	36.8	36.84	8.79	10.68
Cash From Operations, 5 Yr. CAGR %	29.88	16.33	37.42	68.39	25.37
Capital Expenditures, 5 Yr. CAGR %	29.61	12.51	24.51	36.22	49.41
Levered Free Cash Flow, 5 Yr. CAGR %	42.34	21.13	73.39	15.68	18.17
Unlevered Free Cash Flow, 5 Yr. CAGR %	42.43	21.13	73.39	15.68	18.17